Top News
Latest News
REGULATORY
12 Feb 2026
mRNA Makers Face a More Exacting Europe
Draft guidance signals tougher standards for mRNA vaccines and a shift toward long-term regulatory rigor
INNOVATION
6 Feb 2026
From Concept to Clinic, Circular RNA Faces Its Test
A December 2025 deal between Circurna and uBriGene highlights how circular RNA is shifting from promise to production
TECHNOLOGY
4 Feb 2026
Algorithms Are Now Europe’s Hottest Biotech Talent
By 2025, AI is speeding up mRNA design and redrawing biotech’s competitive lines across Europe
PARTNERSHIPS
8 Dec 2025
Can BioNTech’s CureVac Deal Spark a Biotech Revival?
BioNTech’s $1.25bn acquisition of CureVac brings two early mRNA pioneers together as Europe seeks scale in a competitive global market
PARTNERSHIPS
3 Dec 2025
A Power Partnership Pushes Europe’s mRNA Ambitions
Ethris and Thermo Fisher team up to scale stable mRNA innovations and advance the SNIM RNA platform
MARKET TRENDS
24 Oct 2025
From Covid to Cancer, Europe’s mRNA Strategy Takes Shape
Targeted funding and new facilities show a steady push to extend mRNA science beyond Covid-era vaccines
topics on the agenda
ESTABLISHING AN “RNA COOPERATIVE” TO CO-DEVELOP AN mRNA VACCINE
Day 1: WEDNESDAY, 22 JULY, 2026
09:00 - 09:25
NOVEL APPROACH TO IDENTIFY BIOMARKERS FOR mRNA-BASED THERAPEUTICS AND VACCINES
Day 1: WEDNESDAY, 22 JULY, 2026
09:30 - 09:55
ENABLING RAPID mRNA VACCINE DEVELOPMENT WITH CELL-FREE DNA TEMPLATES FOR PANDEMIC PREPAREDNESS
Day 1: WEDNESDAY, 22 JULY, 2026
10:00 - 10:25
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.